Progress in hematopoietic stem cell transplantation for autoimmune diseases

References

• Marmont AM. Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract. Res. Clin. Haematol. 17(2), 223–232 (2004).
   PubMed Web of Science ®Google Scholar
• van Bekkum DW. Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract. Res. Clin. Haematol. 17(2), 201–212 (2004).
   PubMed Web of Science ®Google Scholar
• Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, van Bekkum DW. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant. 8(5), 333–338 (1991).
   PubMed Web of Science ®Google Scholar
• Roep BO, Atkinson M. Animal models have little to teach us about Type 1 diabetes: 1. In support of this proposal. Diabetologia 47(10), 1650–1656 (2004).
   PubMed Web of Science ®Google Scholar
• Ikehara S, Yasumizu R, Inaba M et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc. Natl Acad. Sci. USA 86(9), 3306–3310 (1989).
   PubMed Web of Science ®Google Scholar
• Marmont A, Gratwohl A, Vischer T. Haemopoietic precursor-cell transplants for autoimmune diseases. Lancet 345, 978 (1995).
   PubMed Web of Science ®Google Scholar
• Tamm M, Gratwohl A, Tichelli A, Perruchoud AP, Tyndall A. Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease. Ann. Rheum. Dis. 55(10), 779–780 (1996).
   PubMed Web of Science ®Google Scholar
• Davidson A, Diamond B. Autoimmune diseases. N. Engl. J. Med. 345(5), 340–350 (2001).
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296(5566), 298–300 (2002).
   PubMed Web of Science ®Google Scholar
• Matzinger P. The danger model: a renewed sense of self. Science 296(5566), 301–305 (2002).
   PubMed Web of Science ®Google Scholar
• Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 85(3), 291–297 (1996).
   PubMed Web of Science ®Google Scholar
• Shevach EM. CD4+ CD25+ suppressor T-cells: more questions than answers. Nature Rev. Immunol. 2(6), 389–400 (2002).
   PubMed Web of Science ®Google Scholar
• Kamradt T, Mitchison NA. Tolerance and autoimmunity. N. Engl. J. Med. 344(9), 655–664 (2001).
   PubMed Web of Science ®Google Scholar
• Nelson JL, Torrez R, Louie FM, Choe OS, Storb R, Sullivan KM. Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. J. Rheumatol. Suppl. 48, 23–29 (1997).
   PubMedGoogle Scholar
• Kashyap A, Forman SJ. Autologous bone marrow transplantation for non-Hodgkin’s lymphoma resulting in long-term remission of coincidental Crohn’s disease. Br. J. Haematol. 103(3), 651–652 (1998).
   PubMed Web of Science ®Google Scholar
• McKendry RJ, Huebsch L, Leclair B. Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year follow-up. Arthritis Rheum. 39(7), 1246–1253 (1996).
   PubMed Web of Science ®Google Scholar
• Sonwalkar SA, James RM, Ahmad T et al. Fulminant Crohn’s colitis after allogeneic stem cell transplantation. Gut 52(10), 1518–1521 (2003).
   PubMed Web of Science ®Google Scholar
• Minchinton RM, Waters AH, Kendra J, Barrett AJ. Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft. Lancet 2(8299), 627–629 (1982).
   PubMed Web of Science ®Google Scholar
• Sturfelt G, Lenhoff S, Sallerfors B, Nived O, Truedsson L, Sjoholm AG. Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor. Ann. Rheum. Dis. 55(9), 638–641 (1996).
   PubMed Web of Science ®Google Scholar
• Tyndall A, Gratwohl A. Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease. Curr. Opin. Hematol. 4(6), 390–394 (1997).
   PubMedGoogle Scholar
• McSweeney PA, Nash RA, Storb R, Furst DE, Gauthier J, Sullivan KM. Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. J. Rheumatol. Suppl. 48, 79–84 (1997).
   PubMedGoogle Scholar
• Gratwohl A, Passweg J, Bocelli-Tyndall C et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 35(9), 869–879 (2005).
   PubMed Web of Science ®Google Scholar
• Fassas A, Passweg JR, Anagnostopoulos A et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J. Neurol. 249(8), 1088–1097 (2002).
   PubMed Web of Science ®Google Scholar
• Farge D, Marolleau JP, Zohar S et al. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre Phase I–II study. Br. J. Haematol. 119(3), 726–739 (2002).
   PubMed Web of Science ®Google Scholar
• Binks M, Passweg JR, Furst D et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann. Rheum. Dis. 60(6), 577–584 (2001).
   PubMed Web of Science ®Google Scholar
• Farge D, Passweg J, van Laar JM et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann. Rheum. Dis. 63(8), 974–981 (2004).
   PubMed Web of Science ®Google Scholar
• McSweeney PA, Nash RA, Sullivan KM et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 100(5), 1602–1610 (2002).
   PubMed Web of Science ®Google Scholar
• Snowden JA, Passweg J, Moore JJ et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J. Rheumatol. 31(3), 482–488 (2004).
   PubMed Web of Science ®Google Scholar
• Moore J, Brooks P, Milliken S et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 46(9), 2301–2309 (2002).
   PubMed Web of Science ®Google Scholar
• Wulffraat NM, Sanders EA, Kamphuis SS et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum. 44(3), 728–731 (2001).
   PubMed Web of Science ®Google Scholar
• Wulffraat NM, de Kleer IM, Prakken BJ, Kuis W. Stem cell transplantation for autoimmune disorders. Refractory juvenile idiopathic arthritis. Best Pract. Res. Clin. Haematol. 17(2), 277–289 (2004).
   PubMed Web of Science ®Google Scholar
• Jayne D, Passweg J, Marmont A et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13(3), 168–176 (2004).
   PubMed Web of Science ®Google Scholar
• Jayne D, Tyndall A. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13(5), 359–365 (2004).
   PubMedGoogle Scholar
• Traynor AE, Barr WG, Rosa RM et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum. 46(11), 2917–2923 (2002).
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Snowden JA, Lobo A, Beglinger C, Tyndall A. Stem cell transplantation for inflammatory bowel disease: practical and ethical issues. Gut 46(6), 869–872 (2000).
   PubMedGoogle Scholar
• Oyama Y, Craig RM, Traynor AE et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease. Gastroenterology 128(3), 552–563 (2005).
   PubMed Web of Science ®Google Scholar
• De Stefano P, Zecca M, Giorgiani G, Perotti C, Giraldi E, Locatelli F. Resolution of immune haemolytic anaemia with allogeneic bone marrow transplantation after an unsuccessful autograft. Br. J. Haematol. 106(4), 1063–1064 (1999).
   PubMedGoogle Scholar
• Marmont AM, Gualandi F, Van Lint MT, Bacigalupo A. Refractory Evans’ syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant. 31(5), 399–402 (2003).
   PubMed Web of Science ®Google Scholar
• Slavin S, Nagler A, Varadi G, Or R. Graft vs. autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp. Hematol. 28(7), 853–857 (2000).
   PubMed Web of Science ®Google Scholar
• Rouquette-Gally AM, Boyeldieu D, Gluckman E, Abuaf N, Combrisson A. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br. J. Haematol. 66(1), 45–47 (1987).
   PubMedGoogle Scholar
• Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients. Transplantation 46(2), 238–240 (1988).
   PubMedGoogle Scholar
• Snowden JA, Heaton DC. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br. J. Dermatol. 137(1), 130–132 (1997).
   PubMed Web of Science ®Google Scholar
• Baron FA, Hermanne JP, Dowlati A et al. Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 21(9), 951–954 (1998).
   PubMed Web of Science ®Google Scholar
• Khorshid O, Hosing C, Bibawi S et al. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J. Rheumatol. 31(12), 2513–2516 (2004).
   PubMed Web of Science ®Google Scholar
• Burt RK, Oyama Y, Verda L et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum. 50(8), 2466–2470 (2004).
   PubMed Web of Science ®Google Scholar
• Gratwohl A, Tyndall A. Hematopoietic stem cell transplantations in treatment of autoimmune diseases. Z. Rheumatol. 56(4), 173–177 (1997).
   PubMedGoogle Scholar
• Gratwohl A, Passweg J, Gerber I, Tyndall A. Stem cell transplantation for autoimmune diseases. Best Pract. Res. Clin. Haematol. 14(4), 755–776 (2001).
   PubMed Web of Science ®Google Scholar
• Kalwak K, Gorczynska E, Toporski J et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br. J. Haematol. 118(1), 74–89 (2002).
   PubMedGoogle Scholar
• Peggs KS, Verfuerth S, Pizzey A et al. Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection. Biol. Blood Marrow Transplant. 9(3), 198–205 (2003).
   PubMed Web of Science ®Google Scholar
• Douek DC, Vescio RA, Betts MR et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355(9218), 1875–1881 (2000).
   PubMed Web of Science ®Google Scholar
• Crippa F, Holmberg L, Carter RA et al. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol. Blood Marrow Transplant. 8(5), 281–289 (2002).
   PubMedGoogle Scholar
• Aubert G, Hassan-Walker AF, Madrigal JA et al. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J. Infect. Dis. 184(8), 955–963 (2001).
   PubMed Web of Science ®Google Scholar
• Einsele H, Bertz H, Beyer J et al. Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann. Hematol. 82(Suppl. 2), S175–S185 (2003).
   Google Scholar
• Clave E, Agbalika F, Bajzik V et al. Epstein–Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy. Transplantation 77(1), 76–84 (2004).
   PubMed Web of Science ®Google Scholar
• Storek J, Dawson MA, Storer B et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97(11), 3380–3389 (2001).
   PubMed Web of Science ®Google Scholar
• Farge DHC, Carmagnat M, Daneshproum M et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum. (2005) (In Press).
   PubMedGoogle Scholar
• Petri M, Jones RJ, Brodsky RA. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum. 48(1), 166–173 (2003).
   PubMed Web of Science ®Google Scholar